Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19803983 | 0.89 | MMP1 (0.36) | MMP1MMP2 | |
| SCHEMBL17036747 | 0.88 | MMP1 (0.34) | MMP1MMP2 | |
| SCHEMBL21276550 | 0.85 | — | — | |
| SCHEMBL17036727 | 0.85 | MMP1 (0.31) | MMP1MMP2 | |
| SCHEMBL20730702 | 0.85 | — | — | |
| SCHEMBL18311508 | 0.79 | MMP1 (0.39) | MMP1MMP2 | |
| SCHEMBL19240602 | 0.78 | MMP1 (0.36) | MMP1MMP2 | |
| SCHEMBL17039331 | 0.73 | MMP1 (0.42) | MMP1MMP2 | |
| SCHEMBL17039329 | 0.72 | MMP1 (0.40) | MMP1MMP2 | |
| SCHEMBL17036737 | 0.70 | MMP1 (0.36) | MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2023-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | CFD, TFPI, CFH | MMP1 1735/4885MMP2 527/4885NAAA 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.